In November 2017, I noted on Accrol (ACRL) bailout fundraising… at half of IPO price of only 17 months ago!. That was at 50p per share – but there was still much worse to follow. The shares had recovered from lows to a recent more than 20p – but that was before today a “Trading Update”…
A “Board and Senior Management Changes” announcement from tissue products manufacturing group Accrol (ACRL) including “it is a statement of how much progress we have made that Accrol is able to attract an operational leader of Mark's capability”. Let’s take a look…
Tissue products manufacturing group Accrol (ACRL) has updated that it received valid applications of 287.64% of the new shares available under an open offer to raise up to £1.935 million at 15p per share. That compares with a 22.5p prior close, but also more than 130p as recently as October 2017, so where now?...
In June 2016 tissue products manufacturer Accrol (ACRL) listed on AIM, raising £63.5 million at 100p per share. Just seventeen months later it was bailout fundraising at half of the IPO price but still recently “revised banking arrangements” have been necessary and now at 3:08pm on 15th May 2018…
